Haleon (NYSE:HLN) Shares Gap Up – Still a Buy?

Haleon plc (NYSE:HLN)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $9.79, but opened at $10.20. Haleon shares last traded at $10.11, with a volume of 1,391,381 shares traded.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Haleon presently has a consensus rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Stock Performance

The stock has a market capitalization of $46.06 billion, a P/E ratio of 29.93, a price-to-earnings-growth ratio of 2.82 and a beta of 0.28. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a 50-day moving average price of $9.59 and a two-hundred day moving average price of $9.84.

Haleon (NYSE:HLN) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. The company had revenue of $3.54 billion for the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. On average, equities analysts forecast that Haleon plc will post 0.43 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in HLN. Sierra Ocean LLC acquired a new position in shares of Haleon in the 4th quarter valued at about $26,000. Versant Capital Management Inc raised its stake in Haleon by 2,029.1% during the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after buying an additional 3,348 shares during the period. Geneos Wealth Management Inc. acquired a new position in Haleon during the 4th quarter worth approximately $35,000. Toronto Dominion Bank raised its stake in Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after buying an additional 3,470 shares during the period. Finally, Spire Wealth Management acquired a new position in Haleon during the 4th quarter worth approximately $39,000. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.